Skip to main content



Clinical Insights
Dr A.J. Gunn and colleagues discuss their approach to liver-directed therapies for transplant-eligible and near transplant-eligible patients at the University of Alabama in Birmingham, Alabama.
Announcing CIOctober, an online experience providing practical interventional oncology education every Tuesday this October. Register today!
Dr Philip Low of On Target Laboratories discusses OTL38, a novel, tumor-targeted dye used to guide cancer surgery.
Ann Podrasky, MD, FSRU, compares the various guidelines available for the ultrasound evaluation of thyroid nodules and discusses the utility of various imaging modalities.
Riad Salem, MD, discusses the modified RECIST criteria and the evolution in the assessment of patient response after localized treatment of hepatocellular carcinoma. 
Back to Top